Infographic | October 4, 2022

Phase II/III Outsourcing Partner Selection Attributes

Source: ISR Reports

In Q1 & Q2 of 2022 ISR surveyed 132 sponsors worldwide who outsource Phase II/III studies and asked them to identify attributes that are important to them when selecting an outsourcing partner. The research revealed that respondents valued Operational excellence and Therapeutic expertise quite highly when choosing a provider for their Phase II/III studies. To learn more about outsourcers Phase II/III study needs, market dynamics, and their use of different service providers, Check out ISR’s Phase II/III Market Outlook report preview.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader